Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Turkish Stocks: Akbank, Eczacibasi, Turkish Airlines Are Active

Jan. 23 (Bloomberg) -- Turkey’s benchmark ISE National 100 Index rose for a sixth day, adding 0.5 percent to 55,186.21 at the close in Istanbul. The index has increased 7 percent over the past six days.

The following were among the active equities in the Turkish market today. Stock symbols are in parentheses.

Akbank TAS (AKBNK TI), the lender owned by Citigroup Inc. and Haci Omer Sabanci Holding AS, fell 1.5 percent to 6.64 liras while the Turkish banking index increased 0.3 percent. Akbank was cut to “sell” from “neutral” and is the “least-preferred” among Turkish banks because of its share price premium versus peers, UBS said today.

EIS Eczacibasi Ilan & Sinai & Finansal Yatirimlar Sanayi & Ticaret AS (ECILC TI), a drugmaker, gained 1.1 percent to 1.78 liras. The company entered into an agreement with Germany’s MediGene AG to supply its Veregen ointment for genital warts, according to a statement from MediGene today.

Turk Hava Yollari AO (THYAO TI), or Turkish Airlines, jumped 3.7 percent to 2.27 liras. The company is a potential buyer of Poland’s state airline Polskie Linie Lotnicze LOT SA, Poland’s Treasury Ministry spokeswoman Madalena Kobos said today.

To contact the reporter on this story: Benjamin Harvey in Istanbul at bharvey11@bloomberg.net

To contact the editor responsible for this story: Gavin Serkin at gserkin@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.